Abdul El-Sayed, a Democratic candidate for the U.S. Senate in Michigan, has spoken out against government restrictions on sex change procedures, asserting that doctors, like himself, should be able to determine treatment plans for their patients. These comments surfaced during a rally at Michigan State University when he was asked about safeguarding access to sex changes. El-Sayed, who highlights his background as a physician in his campaign, aims to become the first doctor to serve as a Democratic senator in decades. However, it’s notable that he has never held a medical license in either Michigan or New York.
In his remarks, El-Sayed expressed confidence in his peers, stating, “I went to a whole a– medical school, everybody I graduated with also went to whole a– medical school.” He emphasized the importance of decisions regarding healthcare being made between a patient—and their guardians if they’re minors—and their doctor without interference from the government.
His comments come at a time when the Trump administration has been implementing significant measures to limit minors’ access to procedures related to gender transition, including hormone therapy and surgeries. Recently, the Justice Department reported that Mount Sinai and other hospitals have ceased providing such procedures to children due to agreements with the Trump administration.
El-Sayed’s campaign centers around the concept of Medicare for All, advocating for government-run healthcare, while maintaining that government should not dictate the specifics of medical treatment. He stated, “I don’t think the government gets to have a say about what health care is provided in what circumstances and why,” suggesting that healthcare decisions should primarily reside between the patient and their medical provider.
He also pointed out that Republicans seem to share his view that healthcare decisions should remain private, referencing the “Right to Try” legislation that allows terminally ill patients access to experimental treatments. “Because conservatives fought for a very long time for this legislation,” he noted, underlining a shared belief in the autonomy of patients in healthcare choices.
However, it’s important to recognize that research surrounding the effectiveness of using hormones and puberty blockers for treating gender dysphoria is still limited. The World Professional Association for Transgender Health, which provides guidelines used by various medical associations, is currently facing legal challenges from the Federal Trade Commission (FTC) over allegations that it misrepresented the medical consensus on sex-change procedures and their safety.
The FTC has raised concerns about the lack of information on potential side effects linked to these treatments, which may include issues like incontinence and mood disturbances. Additionally, countries with socialized healthcare systems, like England, have started imposing restrictions, pausing certain treatments for minors after scrutinizing the supporting research.
El-Sayed’s office has not yet commented on his medical qualifications amidst the ongoing discussion.
